Does Hims Offer TRT? Current Options, Launch Plans and Costs
Separate Hims' current enclomiphene offering from planned injectable and oral TRT. Check product availability, payment terms and what to confirm before enrollment.
PeakedLabs editorial standard. We organize provider, pricing, lab-monitoring, and safety signals for research. This is not medical advice; use it to prepare better questions for a licensed clinician.
Executive Summary
At our September 17, 2026 check, the Hims testosterone page listed enclomiphene-based Testosterone Rx care, but described injectable testosterone and oral Kyzatrex as coming in 2026. Its FAQ still said injections were not currently offered. Do not treat either planned TRT launch as confirmed availability for a new patient.
Correction: an earlier version of this article incorrectly described Kyzatrex as already available through an exclusive Hims partnership. We removed that claim. Hims' current page says it is not affiliated with or endorsed by Kyzatrex's manufacturer, Marius Pharmaceuticals.
This is a dated check of public product information, not a test purchase or clinical recommendation. Before paying, ask which exact treatment can be evaluated for a patient in your state. Start with the provider comparison or the TRT research guide to organize your questions.
Free decision tools
Turn the research into a provider shortlist
Compare published pricing, lab models, clinician access, treatment focus, and state coverage before you enroll. PeakedLabs scoring stays independent from commercial relationships.
At-a-Glance Comparison
Availability snapshot, checked September 17, 2026 against the Hims testosterone page. Current, planned and individually eligible are different statuses.
| Option | What the public page showed | What to confirm |
|---|---|---|
| Enclomiphene-based Testosterone Rx | An available assessment pathway; prescription is conditional | Exact formulation, clinical eligibility, state coverage and final charges |
| Injectable testosterone | Planned launch; FAQ still says unavailable | A live offering for your state, rather than a future-launch announcement |
| Kyzatrex oral testosterone | Planned launch, not confirmed current access | Actual prescribing availability and product-specific price |
Enclomiphene and testosterone replacement are different questions
Enclomiphene is not testosterone itself. Hims describes its offering as supporting the body's own testosterone production. Its page also discloses that the compounded product is not FDA-approved. FDA guidance on compounded medicines explains that compounded medicines do not undergo FDA premarket review for safety, effectiveness and quality.
Ask a licensed clinician to explain the proposed medicine, its approval status, alternatives, uncertainties and monitoring. A comparison article cannot determine a diagnosis from a lab threshold, promise fertility preservation or choose a prescription for you. A brand's broader hormone category does not make every product in it interchangeable.
Common failure mode: Using a familiar brand or a product category label as a substitute for understanding the actual prescription.
Execution Checklist
- Write down the exact proposed active ingredients and formulation.
- Ask why the clinician recommends that option in your circumstances.
- Discuss fertility goals before treatment decisions; do not assume a marketing claim guarantees an outcome.
- Request a clear follow-up and adverse-effect contact plan.
A monthly headline may require a much larger payment
The Hims testosterone page advertised enclomiphene treatment starting at $99 per month with a ten-month plan paid upfront. That is a $990 treatment commitment at the stated starting rate, not evidence of a $99 month-to-month checkout or a complete first-year bill.
Compare cash due at enrollment, the period covered, separately charged testing, renewal terms and what happens when a clinician does not prescribe. Request the actual checkout total. In the cost calculator, label each quote accurately; do not compare an enclomiphene plan with a TRT quote as though they were the same treatment. Keep any missing fee on your unanswered-questions list rather than silently treating it as free.
Common failure mode: Multiplying a promotional monthly equivalent by twelve while overlooking the upfront commitment, excluded items or renewal period.
Execution Checklist
- Capture the offer date and payment interval.
- Confirm assessment and laboratory charges separately.
- Read cancellation, refund and renewal terms before prepaying.
- Compare only clinically appropriate options, not just headline prices.
How to verify a launch without starting the wrong enrollment
A launch announcement describes an intention. A marketing page, intake pathway and prescribing availability can be at different stages. Our source snapshot is useful precisely because it identifies that uncertainty rather than turning it into a confident yes.
Ask the care team whether the specific product is currently offered for assessment in your state, which evaluation steps are required, and when payment becomes nonrefundable. Save the answer with its date. Recheck before enrolling. If already receiving treatment elsewhere, use the appointment planner to coordinate the discussion with both care teams; do not interrupt or modify treatment based on a website launch status.
Common failure mode: Enrolling for one pathway while assuming a future product will automatically become available or be clinically appropriate.
Execution Checklist
- Name the product rather than asking only about testosterone support.
- Distinguish an assessment from approval for a prescription.
- Confirm availability for your location and circumstances.
- Keep responsibility for any existing care handoff explicit.
What this comparison can and cannot establish
This page records public commercial claims and helps readers ask better questions. We have not tested care quality, verified individual eligibility or established that Hims is superior to another provider. No independent medical-review credit is claimed for this article.
For the next comparison, use enclomiphene provider research for that specific category or the provider directory for broader options. Read each source date and pricing qualifier. A clinic listing, editorial score or affiliate link is not a clinical endorsement.
Common failure mode: Replacing an outdated blanket claim with an equally unsupported ranking or treatment recommendation.
Execution Checklist
- Use the current provider source as the final check on commercial terms.
- Ask your clinician to assess medical suitability.
- Treat unverified information as unknown.
- Revisit this snapshot when the provider changes its launch or pricing information.
Internal Resources to Compare Next
Use these pages to validate assumptions before spending. Cross-checking provider model details with treatment-specific pages is the fastest way to reduce preventable cost drift in month two and month three.
Compare Providers Before You Purchase
Compare current provider information, then confirm the proposed treatment and total charges directly. Our tools organize research; they do not prescribe or guarantee access.
Disclosure: PeakedLabs may earn a commission from partner links. Editorial scoring and rankings remain independent.
Frequently Asked Questions
Does Hims currently offer TRT injections?
At our September 17, 2026 check, the Hims testosterone page still described injections as a planned launch and its FAQ said they were unavailable. Verify current access before enrollment.
Is Kyzatrex already available through Hims?
The public page we checked still presented Kyzatrex as a planned launch. This is not confirmation of present prescribing access. Our earlier claim that it had already launched through an exclusive partnership was incorrect.
Is the $99 Hims price a monthly payment?
The cited starting offer required ten months paid upfront: $990 at the stated rate. Obtain the full checkout and testing charges; do not assume a month-to-month agreement.
Is enclomiphene the same as TRT?
No. Enclomiphene is not exogenous testosterone. Ask the clinician to explain the proposed treatment and its regulatory status rather than treating all hormone offerings as interchangeable.
Read next
Hims vs Roman vs Maximus TRT Comparison (2026): The One Difference Nobody Mentions
Most men searching 'Hims vs Roman vs Maximus TRT' are comparing what they think are three equivalent testosterone providers. They are not. Hims prescribes enclomiphene — a SERM that stimulates natural production — not exogenous testosterone. That distinction changes the protocol, the lab requirements, the costs, and who each platform is actually right for.
How to Choose a TRT Clinic: What to Look For and What to Avoid (2026)
Most TRT clinic rankings are written by the clinics. This guide gives you the neutral evaluation rubric — five quality variables, seven red flags, and a decision framework — so you can identify the right provider before you commit to one.
Best Online Enclomiphene Providers: Compare Prices, Terms and Evidence
Hims, Maximus and TRT Nation publish enclomiphene offerings, but a listed product is not proof of personal eligibility or equivalent care. Compare the source, payment terms and follow-up responsibilities.
The newsletter
Get the latest peptide & TRT research
Weekly evidence-based updates on protocols, costs, and telehealth provider quality.
Free forever. Unsubscribe anytime. We never sell your email.